Niagen Bioscience, Inc. Cash Flow Quality Index
Niagen Bioscience, Inc. cash flow quality index. Niagen Bioscience, Inc. (NAGE) has a Cash Flow Quality Index of 2.88x as of June 2026. Operating cash flow of $2.77 Million exceeds net income of $963.00K, indicating high earnings quality where cash backs reported profits. See NAGE FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Niagen Bioscience, Inc. (2024–2025)
Cash flow quality index of Niagen Bioscience, Inc. from 2024 to 2025. Historical Cash Flow Quality Index for Niagen Bioscience, Inc. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Niagen Bioscience, Inc. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Niagen Bioscience, Inc. Cash Flow Quality Index by Year (2024–2025)
Niagen Bioscience, Inc. cash flow quality index by year from 2024 to 2025. Year-by-year earnings quality comparison for Niagen Bioscience, Inc.. For the full cash flow conversion analysis, see NAGE operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.77x | $13.44 Million | $17.38 Million | ▼ -45.4% |
| 2024 | 1.42x | $12.11 Million | $8.55 Million | — |